CClinicalTrials.gg
CompletedNCT03813888Updated Jan 23, 2019

Effect of Arshvidya After School Program on Cognitive Processes in Elementary School Children

An interventional study of Arsha Vidya chldren's Group and Usual Activity group in Cognitive Change, sponsored by NMP Medical Research Institute. Completed at 1 site in India. Open to participants aged 8 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-23.

Sponsored by NMP Medical Research Institute · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Mar 2017, registered Jan 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
8 Years to 11 Years
Sex
All
01

Study summary

The impact of Arsha Vidya program on cognitive performance was examined in elementary school children. The study compares the effects of arsha vidya after school routine with usual after school routine in healthy 8-11 year-old Indian children.

The main objective of the study is to investigate the effect on cognitive function, behaviour and emotions.

02

Conditions studied

  • Cognitive Change
03

In context

Lead sponsor

NMP Medical Research Institute is the lead sponsor of 30 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be 8 - 11 years of age at the start of the intervention
  • Healthy Children
  • Not start new activity within the intervention period
  • Parental conset
  • Parents to allow and participate where needed in intervention

Exclusion criteria

Exclusion Criteria:

  • Serious chronic illnesses and diseases
  • Diagnosed with any psychiatric illness
  • Intake of medication that may affect study outcomes
  • not able to continue for 12-weeks of participation
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Arsha Vidya Group

    After school, children joined regular sessions in Arsha Vidya study centre to practice, vedic chants, vedanta reading, yoga and group activities within the ashram.

    Other: Arsha Vidya chldren's Group

  • Other
    Usual Activity Group

    After school, control group were asked to conitue their usual routine.

    Other: Usual Activity group

Interventions

  • OtherArsha Vidya chldren's Group

    Yoga, Vedic chants, Vedant sessions, Gita sessions and group activities within the Gurukulam (centre)

  • OtherUsual Activity group

    Usual after school activities at home.

06

What researchers measure

Primary outcomes

  1. Cognitive function

    Cognitive functions measured by the Cambridge Neuropsychological Test Automated Battery

    Time frame: Change from baseline to 12-week

Secondary outcomes

  1. Behaviour

    Behaviour measured by the Behavior Rating Inventory of Executive Function

    Time frame: Change from Baseline to 12-weeks

  2. Attention

    Attention measured by the D2 Test of Attention

    Time frame: Change from baseline to 12-weeks

07

Study locations

1 site
  • NMP Medical Research Institue
    Jaipur, Rajasthan 302019, India
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03813888
Lead sponsor
NMP Medical Research Institute
Collaborators
Warwick Research Services, Arsha Vidya Study Centre, Tamilnadu, India
Responsible party
Sponsor
First posted
Jan 23, 2019
Start date
Mar 21, 2017
Primary completion
Jan 15, 2018
Completion
Mar 12, 2018
Last update
Jan 23, 2019

Study contacts

Neha Sharma, PhD
principal investigator · Warwick Research Services
Puneet Sharma
study director · Sarvatra International, Dubai
Buddhatmananda Saraswati
study chair · Arsha Vidya Study Centre, India

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion